Analgesics : Market Research Report

Analgesics

Published by: Global Industry Analysts

Published: Oct. 1, 2008 - 512 Pages

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS: Study Reliability and Reporting Limitations; Disclaimers; Quantitative Techniques & Analytics; Ibuprofen
II. EXECUTIVE SUMMARY: 1. Global Analgesics Market Overview; Pain Therapeutic Market; Liquid Analgesics Register Rapid Growth; Boom in Demand for Topical Analgesic Patches; 2. Product Overview; A Brief History; Chronic Pain; Nonsteroidal Anti-Inflammatory Drugs (NSAIDs); Common NSAIDs; Side Effects; PolyAspirin: The Safer and More Potent Polymer Variant of Aspirin; Acetaminophen Protects Heart Muscle; Table 1: Opioid Analgesics Market: Percentage Share of Opioid / Acetaminophen Combination Products in the Opioid Script Volume (includes corresponding Graph/Chart); 3. Industry Dynamics; Escalating R&D Costs: A Boon or Bane?; Novel Therapies to Propel Opioid and Non-Opioid Therapies; 4. Recent Clinical Trials; PLx Initiates Clinical Trial For Aspirin-PC; ProEthic Pharmaceuticals Releases Ibudone for Acute Pain Management; McNeil Brings Chewable TYLENOL® GoTabs Tablets; SSP and Mepha Launch Olfen Patch in Switzerland; SSL International Introduces Easy-To-Swallow Version of Paramol; Purdue Pharma Launches MS Contin, a Narcotic Analgesic; Bitartrate; 6. Recent Industry Activity; Bayer to Acquire Sagmel’s OTC Business; Akela Extends Agreement with Janssen; IOL to Expand Production Capacity; Watson Receives FDA Approval for Oxycodone Hydrochloride and Ibuprofen; Beijing Med-Pharm Inks Agreement with Lotus Healthcare; Ranbaxy and Ethypharm Ink In-licensing Agreement; EC Sanctions Sale of Elan’s Prialt; Bextra (Valdecoxib) Receives Green Signal from Health Canada; 7. Focus on Select Key Players; Bayer Consumer Care (USA); Novartis International AG (Switzerland); Wyeth (USA); Table 2: World Recent Past, Current & Future Analysis for Analgesics by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart); Table 3: World Long-term Projections for Analgesics by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart); Table 4: World Historic Review for Analgesics by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart); Table 5: World 15-Year Perspective for Analgesics by Geographic Region/Country - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 1998, 2008 & 2012 (includes corresponding Graph/Chart); Table 6: World Recent Past, Current & Future Analysis for Internal Analgesics by Geographic Region/ Country - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart); Table 7: World Long-term Projections for Internal Analgesics by Geographic Region / Country - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart); Table 8: World Historic Review for Internal Analgesics by Geographic Region/Country - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart); Table 9: World 15-Year Perspective for Internal Analgesics by Geographic Region/Country - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 1998, 2008 & 2012 (includes corresponding Graph/Chart); Table 10: World Recent Past, Current & Future Analysis for Internal Analgesics by Product Segment - Aspirin, Acetaminophen, Ibuprofen, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart); Table 12: World Historic Review for Internal Analgesics by Product Segment - Aspirin, Acetaminophen, Ibuprofen, and Others Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart)
III-A. MARKET: 1. The United States; A. Market Analysis; Internal Analgesics; Table 35: US Internal Liquid Analgesics Market (2007): Percentage Share Breakdown of Leading Ten Brands by Revenues (includes corresponding Graph/Chart); Pediatric Analgesics: The New Kid on the Block; Patch Relief Gaining Momentum; Strategic Corporate Developments; Major Players; B. Market Analytics; Table 41: US Long-term Projections for Analgesics by Product Segment - Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart); Table 43: US 15-Year Perspective for Analgesics by Product Segment - Percentage Breakdown of Dollar Sales for Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets for 1998, 2008 & 2012 (includes corresponding Graph/Chart); 2. Canada; A. Market Analysis; B. Market Analytics; Table 45: Canadian Long-term Projections for Analgesics by Product Segment - Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart); Table 47: Canadian 15-Year Perspective for Analgesics by Product Segment - Percentage Breakdown of Dollar Sales for Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets for 1998, 2008 & 2012 (includes corresponding Graph/Chart); 3. Japan; A. Market Analysis; B. Market Analytics; Table 52: Japanese 15-Year Perspective for Analgesics by Product Segment - Percentage Breakdown of Dollar Sales for Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets for 1998, 2008 & 2012 (includes corresponding Graph/Chart); 4. Europe; A. Market Analysis; Table 53: Popular Brands of Pain & Inflammation Medication in Europe (2004): Percentage Share of Aspirin, Voltaren, Ibuprofen, Nurofen, Vioxx, Celebre, Tylenol, Aulin, Anadin, and Paracetamol (includes corresponding Graph/Chart); B. Market Analytics; Table 56: European Recent Past, Current & Future Analysis for Analgesics by Product Segment - Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2010 (includes corresponding Graph/Chart); Table 58: European Historic Review for Analgesics by Geographic Region/Country - France, Germany, UK, Italy, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 1991 through 2000 (includes corresponding Graph/Chart); Table 60: European 15-Year Perspective for Analgesics by Geographic Region/Country - Percentage Breakdown of Dollar Sales for France, Germany, UK, Italy, Spain, Russia and Rest of Europe Markets for Years 1998, 2008 & 2012 (includes corresponding Graph/Chart); Table 61: European 15-Year Perspective for Analgesics by Product Segment - Percentage Breakdown of Dollar Sales for Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets for Years 1998, 2008 & 2012 (includes corresponding Graph/Chart); 4a. France; A. Market Analysis; B. Market Analytics; Table 64: French Long-term Projections for Analgesics by Product Segment - Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015(includes corresponding Graph/Chart); Table 66: French 15-Year Perspective for Analgesics by Product Segment - Percentage Breakdown of Dollar Sales for Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets for 1998, 2008 & 2012 (includes corresponding Graph/Chart); 4b. Germany; A. Market Analysis; B. Market Analytics; Table 69: German Long-term Projections for Analgesics by Product Segment - Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart); Table 71: German 15-Year Perspective for Analgesics by Product Segment - Percentage Breakdown of Dollar Sales for Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets for 1998, 2008 & 2012 (includes corresponding Graph/Chart); 4c. The United Kingdom; A. Market Analysis; B. Market Analytics; Table 74: UK Long-term Projections for Analgesics by Product Segment - Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015(includes corresponding Graph/Chart); Table 76: UK 15-Year Perspective for Analgesics by Product Segment - Percentage Breakdown of Dollar Sales for Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets for 1998, 2008 & 2012 (includes corresponding Graph/Chart); 4d. Italy; A. Market Analysis; B. Market Analytics; Table 79: Italian Long-term Projections for Analgesics by Product Segment - Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart); Table 81: Italian 15-Year Perspective for Analgesics by Product Segment - Percentage Breakdown of Dollar Sales for Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets for 1998, 2008 & 2012 (includes corresponding Graph/Chart); 4e. Spain; A. Market Analysis; B. Market Analytics; Table 84: Spanish Long-term Projections for Analgesics by Product Segment - Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015(includes corresponding Graph/Chart); Table 86: Spanish 15-Year Perspective for Analgesics by Product Segment - Percentage Breakdown of Dollar Sales for Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets for 1998, 2008 & 2012 (includes corresponding Graph/Chart); 4f. Rest of Europe; A. Market Analysis; Key Player; B. Market Analytics; Table 88: Rest of Europe Long-term Projections for Analgesics by Product Segment - Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart); Table 90: Rest of Europe 15-Year Perspective for Analgesics by Product Segment - Percentage Breakdown of Dollar Sales for Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets for 1998, 2008 & 2012 (includes corresponding Graph/Chart); 5. Asia-Pacific; A. Market Analysis; Regions - Australia, China and South Korea; Strategic Corporate Developments; B. Market Analytics; Table 92: Asia-Pacific Long-term Projections for Analgesics by Product Segment - Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart); Table 94: Asia-Pacific 15-Year Perspective for Analgesics by Product Segment - Percentage Breakdown of Dollar Sales for Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets for 1998, 2008 & 2012 (includes corresponding Graph/Chart); 6. Latin America; A. Market Analysis; Table 96: Latin American Long-term Projections for Analgesics by Product Segment - Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart); 7. Rest of World; A. Market Analysis; Table 100: Rest of World Long-term Projections for Analgesics by Product Segment - Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart); Table 102: Rest of World 15-Year Perspective for Analgesics by Product Segment - Percentage Breakdown of Dollar Sales for Internal Analgesics (Aspirin, Acetaminophen, Ibuprofen and Others) and External Analgesics Markets for 1998, 2008 & 2012 (includes corresponding Graph/Chart)
III-B. APPENDIX - POPULAR ANALGESIC BRANDS BY REGION: Canada; France; Germany; United Kingdom; Leading Analgesics Brands for Children; Italy; Spain; Rest of Europe; Asia-Pacific; Latin America
IV. COMPETITIVE LANDSCAPE: Total Companies Profiled: 139 (including Divisions/Subsidiaries - 179); Region/Country Players; The United States 48; Canada 4; Japan 8; Europe55; France4; Germany 9; The United Kingdom 13; Italy 8; Spain 2; Rest of Europe 19; Asia-Pacific (Excluding Japan)52; Africa 2; Middle East 10

Abstract

This report analyzes the worldwide markets for Analgesics in Millions of US$. The major product segments analyzed are Internal Analgesics, (Aspirin, Acetaminophen, Ibuprofen, and Others (includes combination drugs)) and External Analgesics. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual forecasts are provided for each region for the period of 2001 through 2015. A ten-year historic analysis is also provided for these markets with annual market analytics. The report profiles 139 companies including many key and niche players worldwide such as Bayer Consumer Care, Bristol-Myers Squibb Co., Johnson & Johnson, McNeil Consumer Healthcare, Novartis International AG, Pfizer, Inc., Reckitt Benckiser Group Plc, W. F. Young, Inc., Wyeth, and Wyeth Consumer Healthcare. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

Adobe Acrobat Reader 7.0 is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Titles available via "online download" are not affected by this and are still delivered to your reading room immediately.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.

Get Full Details About This Report >>

US: 800.298.5699

Int'l: +1.240.747.3093

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 250,000 market research reports, company profiles and country profiles from over 650 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.

Analgesics

Table of Contents

Abstract